Raleigh, NC – October 15, 2024 — Contego Medical, a leader in developing innovative medical devices for cardiovascular procedures, announced the U.S. Food and Drug Administration's (FDA) premarket approval (PMA) of the Neuroguard IEP® System, a unique 3-in-1 carotid stenting system that combines a high-performance stent, an integrated dilation balloon, and integrated filter. The system streamlines the carotid stent procedure by reducing the number of steps and makes it safer by capturing emboli that traditional embolic protection systems do not.
Contego Medical is a North Carolina-based medical device company that designs devices such as embolic protection and thrombectomy equipment for the healthcare industry.